Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
Brigade Hotel Ventures’ Rs 760 crore IPO opens : Should you subscribe or skip ?
24/07/2025
Outward remittances down to $2.3 billion in May : RBI Bulletin
24/07/2025
RBI stepped in to prevent rupee's rise, net bought $1.7 billion
24/07/2025
Small stocks, big surge : Over 50 microcaps soar up to 5,500% despite market turmoil
24/07/2025
India's economy shows resilience amid global tariff challenges, macroeconomic risks
24/07/2025
Fitter & Stronger : Midcaps outperform smallcaps in long term
24/07/2025
